The MDS Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What are novel therapeutic approaches in MDS?

During the 7th European School of Haematology (ESH) Translational Research Conference on Myelodysplastic Syndromes, the MDS Hub spoke to Eva Hellström-Lindberg, Karolinska Institutet, Stockholm, SE. We asked, What are novel therapeutic approaches in MDS?

What are novel therapeutic approaches in MDS?

In this video, Hellström-Lindberg outlines current and novel strategies for MDS-related anemia, high-risk MDS, and managing pre- and post-transplantation relapse. She finishes by summarizing her predictions for changes to MDS prognostic tools in 2021 and beyond.

 

Share: